Effect of adding medical cannabis to analgesic treatment in patients with low back pain related to fibromyalgia: an observational cross-over single centre study

Objective. Low back pain (LBP) occurs in many patients with fibromyalgia (FM). The current study aimed to assess the possible pain and function amelioration associated with medicalcannabis therapy (MCT) in…

Continue ReadingEffect of adding medical cannabis to analgesic treatment in patients with low back pain related to fibromyalgia: an observational cross-over single centre study

Topical Medical Cannabis: A New Treatment for Wound Pain—Three Cases of Pyoderma Gangrenosum

Pain associated with integumentary wounds is highly prevalent, yet it remains an area of significant unmet need within health care. Currently, systemically administered opioids are the mainstay of treatment. However,…

Continue ReadingTopical Medical Cannabis: A New Treatment for Wound Pain—Three Cases of Pyoderma Gangrenosum

A Cost-Effectiveness Model for Adjunctive Smoked Cannabis in the Treatment of Chronic Neuropathic Pain

Background: A recent meta-analysis affirmed the benefit of medicinal cannabis for chronic neuropathic pain, a disabling and difficult-to-treat condition. As medicinal cannabis use is becoming increasingly prevalent among Americans, an exploration…

Continue ReadingA Cost-Effectiveness Model for Adjunctive Smoked Cannabis in the Treatment of Chronic Neuropathic Pain

Pills to Pot: Observational Analyses of Cannabis Substitution Among Medical Cannabis Users With Chronic Pain

Chronic pain is common, costly, and challenging to treat. Many individuals with chronic pain have turned to cannabis as an alternative form of pain management. We report results from an…

Continue ReadingPills to Pot: Observational Analyses of Cannabis Substitution Among Medical Cannabis Users With Chronic Pain

Control of pain initiation by endogenous cannabinoids

The potent analgesic effects of cannabis-like drugs1,2,3,4 and the presence of CB1-type cannabinoid receptors in pain-processing areas of the brain and spinal cord5,6 indicate that endogenous cannabinoids such as anandamide7 may contribute to…

Continue ReadingControl of pain initiation by endogenous cannabinoids

An analgesia circuit activated by cannabinoids

Although many anecdotal reports indicate that marijuana and its active constituent, delta-9-tetrahydrocannabinol (delta-9-THC), may reduce pain sensation1,2, studies of humans have produced inconsistent results3,4,5,6. In animal studies, the apparent pain-suppressing…

Continue ReadingAn analgesia circuit activated by cannabinoids

Cannabinoid CB2 receptor agonist activity in the hindpaw incision: model of postoperative pain

The identification of peripherally expressed CB2 receptors and reports that the selective activation of cannabinoid CB2 receptors produces antinociceptionwithout traditional cannabinergic side effects suggests that selective cannabinoid CB2 receptor agonists might be useful in…

Continue ReadingCannabinoid CB2 receptor agonist activity in the hindpaw incision: model of postoperative pain

CB1 and CB2 receptor agonists promote analgesia through synergy in a murine model of tumor pain.

In light of the adverse side-effects of opioids, cannabinoid receptor agonists may provide an effective alternative for the treatment of cancer pain. This study examined the potency and efficacy of…

Continue ReadingCB1 and CB2 receptor agonists promote analgesia through synergy in a murine model of tumor pain.